Reliv International Leads Dietary Supplement Industry With A Revolutionary Product Backed By Clinical Trial-CardioSentials

Reliv CardioSentials(R), a revolutionary dietary supplement shown to be safe and effective through an independent study.

Reliv CardioSentials(R) contains 1500 mg of phytosterols per serving. Foods containing at least 400 mg of phytosterols taken twice a day (800 mg total), as part of a diet low in saturated fats and cholesterol, may reduce the risk of heart disease.

Reliv CardioSentials was developed by Reliv scientists to help address some of the multiple factors causing the development of heart disease, including the complex balances of "good" and "bad" cholesterol levels, as well as blood glucose levels and oxidative stress.

"Total heart health requires a multi-dimensional approach that addresses the array of factors," said Carl W. Hastings, Ph.D. and Reliv Vice President of Research and Development.

The trial was conducted by Joe Vinson, Ph.D., a Professor of Chemistry at the University of Scranton. The 16-week randomized double-blind, placebo- controlled crossover study (the gold standard of clinical testing) aimed to determine the safety and effectiveness of Reliv CardioSentials(R) in reducing those key risk factors. 

The summary report on the clinical trial states that the overall effect of the program for participants in the study was a significant reduction in the 10-year risk of developing cardiovascular disease.

Specifically, the study concluded that Reliv CardioSentials(R) significantly decreased total cholesterol, LDL (bad) cholesterol and triglycerides in test subjects with high cholesterol. In addition, the product increased HDL (good) cholesterol and reduced blood glucose levels.

 The study tested two groups -- individuals taking statin (cholesterol- lowering) medications and individuals not taking statins. Both groups experienced significant antioxidant benefits from Reliv CardioSentials.

Other findings concluded the following results:
      For those taking statin medications, the product caused no adverse interaction with statin medication and resulted in improvements in their average risk factor because of a decrease in LDL (bad cholesterol).
      For those not taking statins, a daily serving of Reliv CardioSentials(R) significantly reduced total cholesterol, LDL (bad) cholesterol, triglycerides and glucose, and raised HDL (good) cholesterol.

It significantly decreased the overall risk factor for heart disease.

Reliv distributes its products exclusively through its network of independent distributors in the United States and 15 other countries. Reliv's international headquarters is based in Chesterfield, Missouri. For more information about Reliv, contact our website at http://optimumnutrition.reliv.com .

Source:  Reliv International, Inc

Follow our posts on Facebook CLICK HERE
For Information about the Business Opportunity and Products CLICK HERE
Follow us on Twitter CLICK HERE
FREE Internet Marketing Training for any MLM CLICK HERE